Influenza drug prevents SARS-CoV-2 from invading host cells
German and British scientists have discovered that the protease inhibitor aprotinin can prevent the SARS CoV-2 virus from entering host cells.
German and British scientists have discovered that the protease inhibitor aprotinin can prevent the SARS CoV-2 virus from entering host cells.
Universities of Uppsala and Mainz are working separately on a drug against the covid-19 virus. The Swedish medicine is aimed at slowing down the virus, the German medicine is focused on prevention.
German researchers have analyzed what lessons we can learn from dealing with the corona pandemic that might help us get a grip on the climate crisis.
The German Paul Ehrlich Institute (PEI) is confident that a vaccine against the novel SARS CoV-2 coronavirus could be available by the end of 2020.
Researchers from Munich and Ulm have shown how the novel coronavirus suppresses the immune response by disabling protein expression in the ribosomes.
In the weekly ‘follow-up’ section we present a sequel to last week’s best-read article here on Innovation Origins. This week it was the story about […]
Conventional viruses spread most effectively at colder temperatures. Like the flu virus. This strikes every year in winter and costs the lives of as many […]